在一个具有高风险遗传特征的老年sAML患者中,长期进行西他/酸维护治疗
Nora Rebeka Javorniczky1, Olga Grishina2, Inga Hund1
1Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Hugstetterstr. 55., 79106, Freiburg, Germany.
Clinical epigenetics
|November 28, 2023
概括
患有急性髓性白血病 (AML) 的老年患者无法接受诱导治疗,可以实现长期生存. 一名75岁的患者经历了完全缓解和5.3年的生存使用decitabine和ATRA.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床研究 临床研究
背景情况:
- 患有急性髓性白血病 (AML) 的老年患者无法接受标准诱导化疗,预后不佳.
- 疾病稳定是这种患者群体的关键治疗目标.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K